These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6757153)

  • 1. Double-blind clinical trial of domiodol vs S-carboxymethylcysteine in chronic obstructive lung disease.
    Casali L; Rampulla C; Rossi A
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):554-7. PubMed ID: 6757153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative clinical evaluation of two mucolytic agents: S-carboxy-methyl-cysteine and letosteine (author's transl)].
    Blaive B; Lapalus P; Lemoigne F
    Sem Hop; 1978 Oct 8-15; 54(29-32):983-6. PubMed ID: 216094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and functional effects of domiodol and sobrerol in hypersecretory bronchopneumonias].
    Finiguerra M; De Martini S; Negri L; Simonelli A
    Minerva Med; 1981 May; 72(21):1353-60. PubMed ID: 7015178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
    Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
    Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies of the clinical effectiveness of the mucolytic drug, S-carboxymethylcysteine, in the therapy of acute and chronic bronchitis].
    Magliulo E; Bonizzoni D; Cattaneo E; Scevola D; Concia E
    Minerva Med; 1975 Apr; 66(25):1187-97. PubMed ID: 1134660
    [No Abstract]   [Full Text] [Related]  

  • 6. [Letosteine in chronic obstructive bronchopneumopathy].
    Meroni P; Palmieri G; De Bartolo G; Barcellini W; Albrici A; Froldi M
    Clin Ter; 1983 Apr; 105(2):109-18. PubMed ID: 6345052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Mucolytic agents. Polycentric study of a carbocysteine-sobrerol combination].
    Gramiccioni E; Pamparana F; Messa A
    Arch Monaldi Mal Torace; 1989; 44(4-6):791-3. PubMed ID: 2577796
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mucolytic therapy for respiratory system diseases. Clinical-experimental results before and after treatment with Transbronchin].
    Primer G
    Ther Ggw; 1975 Aug; 114(8):1251-66. PubMed ID: 1108276
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of S-carboxymethylcysteine on tracheal mucus velocity.
    Goodman RM; Yergin BM; Sackner MA
    Chest; 1978 Dec; 74(6):615-8. PubMed ID: 367726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domiodol treatment for bronchopulmonary diseases in the paediatric age group: a double-blind controlled clinical trial versus placebo.
    Fiocchi A; Grasso U; Zuccotti G; Arancio R; Riva E; Giovannini M
    J Int Med Res; 1988; 16(1):31-8. PubMed ID: 3280363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mucodine in the treatment of chronic bronchitis].
    Wierzbicka M; Wójcik RA
    Pneumonol Pol; 1981; 49(5):369-76. PubMed ID: 7022385
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term oral carbocisteine therapy in patients with chronic bronchitis. A double blind trial with placebo control.
    Grillage M; Barnard-Jones K
    Br J Clin Pract; 1985 Oct; 39(10):395-8. PubMed ID: 3907681
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucolytic effects of domiodol in tracheostomized patients after total laryngectomy. Double-blind, placebo-controlled, randomized pilot study with four-month follow-up.
    Antonelli A; Carraro A; Donati C; Garrubba V
    Arzneimittelforschung; 1992 Feb; 42(2):126-32. PubMed ID: 1610421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic efficacy and general tolerability of 4-carbomethoxythiazolidine chlorohydrate in a double-blind crossover experiment on chronic obstructive bronchopneumopathy].
    Iaia E
    Boll Chim Farm; 1990; 129(10-11):60S-67S. PubMed ID: 2102704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucolytic treatment in chronic obstructive pulmonary disease. Double-blind comparative clinical trial with N-acetylcysteine, bromhexine and placebo.
    Verstraeten JM
    Acta Tuberc Pneumol Belg; 1979; 70(1):71-80. PubMed ID: 398153
    [No Abstract]   [Full Text] [Related]  

  • 16. [Chronic-obstructive lung diseases. The treatment of chronic-obstructive lung diseases with transbronchin].
    Haage W
    ZFA (Stuttgart); 1978 Jul; 54(21):1099-102. PubMed ID: 685402
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of serous and puruloid bronchial hypersecretions in acute and chronic bronchopneumopathies: our experience with a new mucolytic drug].
    Fossati C
    Clin Ter; 1975 Jul; 74(1):63-82. PubMed ID: 770054
    [No Abstract]   [Full Text] [Related]  

  • 18. [Further study on the possibility of using carbocysteine in cystic fibrosis].
    Ferraris S; Zannini G
    Minerva Pediatr; 1983 Nov; 35(22):1145-50. PubMed ID: 6369102
    [No Abstract]   [Full Text] [Related]  

  • 19. [The effect of theophylline in slow-release or regular preparations in chronic obstructive lung disease. A double-blind study comparing Nuelin Depot, Nuelin and placebo].
    Aamodt T; Lien JT; Haaversen O; Osmundsen K
    Tidsskr Nor Laegeforen; 1983 Jun; 103(17-18):1397-9. PubMed ID: 6353660
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial.
    Allegra L; Cordaro CI; Grassi C
    Respiration; 1996; 63(3):174-80. PubMed ID: 8739489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.